000 01027 a2200265 4500
005 20250517214646.0
008 ####s 0 0 eng d
022 _a1434-9949
024 7 _a10.1007/s10067-018-4131-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDurez, Patrick
245 0 0 _aCorrection to: Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial.
_h[electronic resource]
260 _bClinical rheumatology
_c07 2018
300 _a2017-2018 p.
_bdigital
500 _aPublication Type: Journal Article; Published Erratum
700 1 _aPavelka, Karel
700 1 _aLazaro, Maria Alicia
700 1 _aGarcia-Kutzbach, Abraham
700 1 _aMoots, Robert J
700 1 _aAmital, Howard
700 1 _aGovoni, Marinella
700 1 _aVastesaeger, Nathan
773 0 _tClinical rheumatology
_gvol. 37
_gno. 7
_gp. 2017-2018
856 4 0 _uhttps://doi.org/10.1007/s10067-018-4131-1
_zAvailable from publisher's website
999 _c28382794
_d28382794